Questcor Pays $38M To Settle Securities Class Action
Questcor Pharmaceuticals Inc. on Monday agreed to pay $38 million to end a consolidated securities class action alleging the company lies about the efficacy of its biggest moneymaker, multiple sclerosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article